Breakthrough mRNA technologies, strong U.S. leadership, and rising awareness of RSV risks fuel unprecedented market expansion.Austin, United States, April 27, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

A new study found that infants receiving maternal Respiratory Syncytial Virus (RSV) vaccination or Nirsevimab after birth had ...

A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during the ...

A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and Prevention has ...

After respiratory syncytial virus (RSV) circulation was suppressed early in the COVID-19 pandemic, the number of admissions ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six ...

Children with chronic medical conditions (CMCs) had higher rates of respiratory syncytial virus (RSV)-related hospitalization than healthy children during their first two RSV seasons, with a sustained ...

Background:The COVID-19 pandemic affected the epidemiology of respiratory syncytial virus (RSV). We sought to describe ...